Sign In
close X
The user name and password you entered does not match
the information we have on file.
Forgot your password?
Contact us
close X
Please enter a valid code.
Contact us
Showing Results for malignant neoplasm of urinary bladder
Narrow Results
Content Types
NCI Clinical Trials
Looking for trials? Go to NCI and browse 8,000+ trials
104 Search Results
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Perez and Brady’s Principles and Practice of Radiation Oncology
Perez and Brady’s Principles and Practice of Radiation Oncology
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 54. Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention >
Bladder Cancer Chemoprevention
Three randomized clinical trials have tested the retinoid etretinate in patients following resection of their superficial (noninvasive) bladder tumors, which recur in 40% to 90% of cases. All three studies ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 68. Photodynamic Therapy >
Prostate and Bladder Cancers
For patients who receive definitive radiation therapy for prostate cancer and experience a local recurrence of disease, salvage options are limited. In phase 1 studies of second-generation photosensitizer-mediated PDT in ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 94. Molecular Biology of Bladder Cancer >
Molecular Alterations in Superficial Urothelial Carcinoma
Low-grade Ta papillary UCs are genetically stable and commonly contain point mutations or loss of entire chromosomes of chromosome arms rather than complex chromosomal rearrangements. Recent findings also indicate significant ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 94. Molecular Biology of Bladder Cancer >
Information from Expression and Genomic Microarray Profiling
Microarray analysis provides extensive information that is contributing to improved tumor classification and understanding of UC pathogenesis.155 Molecular signatures for the known histopathologic subtypes (grade and stage), for CIS, the ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 94. Molecular Biology of Bladder Cancer >
Molecular Pathogenesis and Tumor Clonality
UC are commonly multifocal and show frequent recurrence. In many cases, the macroscopically “normal” urothelium shows areas of microscopic dysplasia or CIS, and it is easy to envisage how new ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 95. Cancer of the Bladder, Ureter, and Renal Pelvis >
Cancer of the Bladder (updated 4/4/2013)
Cancers of the bladder can be grouped into three general categories by their stages at presentation: those that do not invade the muscularis propria, muscularis propria–invasive cancers, and metastatic cancers. ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 95. Cancer of the Bladder, Ureter, and Renal Pelvis >
Clinical Presentations and Staging
Bladder cancer is rarely incidentally discovered at autopsy. Indeed, almost all cases show symptoms in the premortem period. The most common presentation is gross painless hematuria. Unexplained frequency and irritative ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 95. Cancer of the Bladder, Ureter, and Renal Pelvis >
Treatment of Nonmuscularis Propria Invasive Bladder Cancer (Ta, Tis, T1) (updated 4/4/2013)
Seventy percent of patients with bladder cancer have disease that does not involve the muscularis propria at presentation. Approximately 15% to 20% of these patients will progress to stage T2 ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 95. Cancer of the Bladder, Ureter, and Renal Pelvis >
Systemic Chemotherapy with Radical Therapy
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 95. Cancer of the Bladder, Ureter, and Renal Pelvis >
Workup
The workup of suspected bladder cancer should include cytology, a cystoscopy, and an upper tract study. The preference for the upper tract study is a renal computed tomography (CT) scan ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 95. Cancer of the Bladder, Ureter, and Renal Pelvis >
Staging
The primary bladder cancer is staged according to the depth of invasion into the bladder wall or beyond (Table 95.1).53 The urothelial basement membrane separates nonmuscularis propria bladder cancers into ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 95. Cancer of the Bladder, Ureter, and Renal Pelvis >
Survival
The probability of survival from bladder cancer following cystectomy is determined by the pathologic stage of the disease. Survival is markedly influenced by the presence or absence of positive lymph ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 95. Cancer of the Bladder, Ureter, and Renal Pelvis >
Complications of Cystectomy and Urinary Diversion
The complications of all types of urinary diversion may be divided into three groups: metabolic, neuromechanical, and surgical. ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 95. Cancer of the Bladder, Ureter, and Renal Pelvis >
Predictors of Outcome
A common feature of all the RTOG protocols was early bladder tumor response evaluation and the selection of patients for bladder conservation on the basis of their initial response to ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 172. Sexual Problems >
Bladder Cancer
The most common presentation of bladder cancer is in the form of transitional cell carcinoma, and although most cases tend to be superficial when first diagnosed, repeated treatments may be ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 172. Sexual Problems >
Considerations for Men
A standard radical cystectomy for treating bladder cancer in men involves the removal of the bladder as well as the prostate, seminal vesicles, vasa deferentia, and the removal or damage ...
Cancer: Principles & Practice of Oncology
Cancer: Principles & Practice of Oncology
Chapter 172. Sexual Problems >
Considerations for Women
The standard radical cystectomy for bladder cancer in women involves the removal of the bladder, urethra, anterior vaginal wall, uterus, and ovaries and it is likely to result in sexual ...
Perez and Brady’s Principles and Practice of Radiation Oncology
Perez and Brady’s Principles and Practice of Radiation Oncology
Chapter 11. Altered Fractionation Schedules >
Bladder Cancer
In the study by Edsmyr et al. (61), T2-4 bladder tumors were randomized to either three 1-Gy daily fractions 4-hour with interfraction intervals to 84 Gy, or a single daily ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 11. Minimally Invasive Surgery for Cancer >
Bladder
Laparoscopic radical cystectomy and urinary diversion is a field in its infancy. Technically demanding and time-consuming, experience is growing slowly in large centers. Early results are encouraging and work continues ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 54. Urologic Cancers: Surgical Management of Kidney, Bladder, Prostate, and Testis Cancers >
Bladder Cancer
Bladder cancer represents the second most common genitourinary tumor, and is the fourth most prevalent noncutaneous malignancy in the United States. There are over 70,980 new cases diagnosed each year ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 54. Urologic Cancers: Surgical Management of Kidney, Bladder, Prostate, and Testis Cancers >
Presentation and Diagnosis
The diagnosis of superficial bladder cancer can be elusive because the symptoms mimic those of other common urologic conditions. Approximately three fourths of patients with bladder cancer present with painless, ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 54. Urologic Cancers: Surgical Management of Kidney, Bladder, Prostate, and Testis Cancers >
Staging and Grading
As early as 1947, Jewett observed an increase in local and distant metastasis as the depth of the primary bladder tumor increased. Later, Jewett (28) noted the correlation of the ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 54. Urologic Cancers: Surgical Management of Kidney, Bladder, Prostate, and Testis Cancers >
Bladder Cancer
As well described in the previous chapter, bladder cancer is more common in men and often presents with hematuria. However, we have noticed that women often present to the urologist ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 55. Adjuvant and Neoadjuvant Treatment for Genitourinary Cancers >
Neoadjuvant Chemotherapy
The administration of neoadjuvant chemotherapy has many advantages. In theory, systemic chemotherapy may reduce the extent of local tumor, while treating occult metastases (63). It can also provide effective therapy ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 55. Adjuvant and Neoadjuvant Treatment for Genitourinary Cancers >
Adjuvant Chemotherapy
The use of adjuvant therapy in bladder cancer holds the theoretical benefit of preventing relapse after definitive therapy by treating micrometastatic disease. Adjuvant therapy offers the advantage of an accurate ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 55. Adjuvant and Neoadjuvant Treatment for Genitourinary Cancers >
Neoadjuvant Chemotherapy for Bladder Preservation
Neoadjuvant chemotherapy with or without bladder radiation or chemoradiation has been administered to patients with muscle-invasive bladder cancer as a bladder-preserving strategy. Many phase 2 studies showed the feasibility of ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 55. Adjuvant and Neoadjuvant Treatment for Genitourinary Cancers >
Bladder Cancer
Paraphrasing Winston Churchill's famous statement praising aviators of Battle of Britain, “Never in the field of human conflict was so much owed by so many to so few” (3), it ...
Human Radiation Injury
Human Radiation Injury
Chapter 32. Urinary Function >
Radiation Tolerance of the Lower Urinary Tract
Emami et al.63 pooled data from a number of studies utilizing radiation to treat pelvic malignancies, and reported the bladder TD 5/5 (5% severe late toxicity at 5 years) is ...
Perry’s The Chemotherapy Source Book, 5e
Perry’s The Chemotherapy Source Book, 5e
Chapter 24. Second Malignancies after Chemotherapy >
Bladder Cancer After Chemotherapy
Bladder cancer associated with chemotherapy was first described in 1964.238 During the 5-year follow-up of 61 patients ...
Perry’s The Chemotherapy Source Book, 5e
Perry’s The Chemotherapy Source Book, 5e
Chapter 35. Chemotherapy of Genitourinary Cancer >
Bladder Cancer
Perry’s The Chemotherapy Source Book, 5e
Perry’s The Chemotherapy Source Book, 5e
Chapter 35. Chemotherapy of Genitourinary Cancer >
Treatment of Urothelial Carcinoma in the Elderly and Patients with Comorbidities
The characteristics of bladder cancer patients require special consideration when designing new treatment regimens. With a peak age at presentation between 60 and 70 years of age, many bladder cancer ...
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Chapter 37. Urinary Bladder >
Perspective and Patterns of Spread
Bladder cancer is a neoplasm of the elderly, peaking at 60 to 80 years of age. Despite its highly varied gross appearance in the bladder, intermittent hematuria, either macroscopic or ...
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Chapter 37. Urinary Bladder >
Pathology
The uroepithelium is subject to numerous excretory products and responds with a proliferative process, often as a benign papilloma, which can become multiple, covering most of the bladder epithelium and ...
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Chapter 37. Urinary Bladder >
TNM Staging Criteria
In their initial phase, bladder cancers tend to be multiple, superficial mucosal and submucosal lesions (stage T1; Fig. 37-3). With invasion into the muscular wall (T2), the tumor spreads, first ...
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Chapter 37. Urinary Bladder >
Summary of Changes Seventh Edition AJCC
The TNM Staging Matrix is color coded for identification of stage group once T and N stages are determined (Table 37-3). The T stage determines stage group. ...
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Chapter 37. Urinary Bladder >
T-oncoanatomy
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Chapter 37. Urinary Bladder >
N-oncoanatomy
Lymph node invasion is common once the tumor has penetrated into the deep muscular layer and the serosa. The lymph nodes most commonly involved are the obturator or hypogastric nodes ...
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Chapter 37. Urinary Bladder >
M-oncoanatomy
Vascular spread, although uncommon, is usually a late event. Dissemination follows the vesical veins into the internal iliac veins and inferior vena cava. Tumor cells could reach the right side ...
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Chapter 37. Urinary Bladder >
Regional Lymph Nodes
The regional lymph nodes draining the bladder include primary and secondary nodal drainage regions. Primary lymph nodes include the external iliac, hypogastric, and obturator basins. The presacral lymph nodes are ...
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Chapter 37. Urinary Bladder >
Rules of Classification and Staging
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Chapter 37. Urinary Bladder >
Prognosis
The limited number of prognostic factors are listed in Table 37-6. ...
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Chapter 37. Urinary Bladder >
Cancer Statistics and Survival
When considered together, the male genital and urinary systems are major sites of malignancy. Prostate cancer alone accounts for 200,000 new patients annually. There are 100,000 new urinary tract cancers ...
Principles of Molecular Diagnostics and Personalized Cancer Medicine
Principles of Molecular Diagnostics and Personalized Cancer Medicine
Chapter 38. Molecular Diagnostics of Bladder and Kidney Cancers >
Tumors of the Urinary Bladder
Bladder cancer is the second most common genitourinary malignancy, accounting for more than 70,000 new cases a year and is estimated to cause more than 14,000 yearly deaths in the ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 15. The Epidemiology of Bladder Cancer >
Demographics
Bladder cancer shows a close to 15-fold international variation in incidence. The highest rates occur among men in southern Europe with age-standardized rates (per world population) close to 40 per ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 15. The Epidemiology of Bladder Cancer >
Environmental Exposures
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 15. The Epidemiology of Bladder Cancer >
Metabolic Genes of Bladder Carcinogens
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 15. The Epidemiology of Bladder Cancer >
Other Risk/Protective Environmental Factors
Although our understanding of bladder cancer epidemiology and etiology focuses around the important contribution of exposure from various sources to carcinogenic arylamines, a number of other potential risk or protective ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 17. Molecular Biology and Prognostic Markers in Bladder Cancer >
Bladder Cancer: The Disease
Bladder cancer comprises a spectrum of tumors that include urothelial carcinomas (UCs, also known as transitional cell carcinomas), squamous cell carcinomas, adenocarcinomas, and a few other subtypes. UC is the ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 17. Molecular Biology and Prognostic Markers in Bladder Cancer >
Bladder Tumorigenesis and Progression: A Molecular Model
Studies over the last two decades have identified many genetic alterations in UC leading to a better understanding of its evolution and progression. Alterations in chromosomes 9 and 17 play ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 17. Molecular Biology and Prognostic Markers in Bladder Cancer >
Molecular Staging of Bladder Cancer
Pathological assessment of UC is based on tumor grade and stage. Pathologic staging systems are based on depth of invasion and assessment of regional and systemic spread of tumor. For ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 17. Molecular Biology and Prognostic Markers in Bladder Cancer >
Bladder Cancer: Examining the Multistep Genetic Process
While single determinant alterations have important prognostic value in UC, they have a limited role given the multifactorial nature of the disease. Several early studies have examined the utility of ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 18. Screening, Early Detection, and Prevention of Bladder Cancer >
Prevention
Bladder cancer prevention can be broadly classified into two main categories: (a) avoidance strategies that focus on the reduction or elimination of known risk factors and (b) chemoprevention strategies that ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 18. Screening, Early Detection, and Prevention of Bladder Cancer >
Urine-Based Markers for Screening
The recent emergence of sensitive markers for bladder cancer has provided new opportunities for early bladder cancer detection. There are currently more than 20 UBMs in various stages of development, ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 18. Screening, Early Detection, and Prevention of Bladder Cancer >
Avoidance Strategies
Cigarette smoking has been studied as a risk factor for the development of bladder cancer for over 50 years (63) and is now widely recognized as a significant risk factor. ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 19. Bladder Cancer Staging >
Clinical Staging of Bladder Cancer
Precise staging information for bladder cancer is obtained through a combination of endoscopic inspection, histologic evaluation of endoscopically obtained biopsy material, physical examination under anesthesia (EUA), and radiographic imaging for ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 19. Bladder Cancer Staging >
Pathologic Staging of Bladder Cancer
The pathologic stage (pTNM) of a tumor represents a summary of clinical staging data collected preoperatively as well as additional data acquired from pathological evaluation of the surgical specimen (bladder, ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 19. Bladder Cancer Staging >
Examination Under Anesthesia
The bimanual examination of the bladder, prostate, rectum, and gynecologic organs is an important part of the overall evaluation of the bladder cancer patient. The EUA can detect locally advanced ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 19. Bladder Cancer Staging >
Radiographic Imaging
The radiographic imaging of the patient with bladder cancer plays a central role in staging and should provide information on the extent of local invasion/extension, the presence of regional metastases, ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 19. Bladder Cancer Staging >
Determination of Nodal and Distant Metastatic Disease
The most common sites of metastasis for invasive bladder cancer include the regional lymph nodes, liver, lung, and bone (40). Both CT and MRI rely on size criteria to detect ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 19. Bladder Cancer Staging >
Local Tumor (T) Staging
The AJCC classifies the local bladder cancer staging according to the level of bladder tumor invasion (Fig. 19.1). Papillary tumors confined to the epithelium are classified as stage Ta. Flat ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 19. Bladder Cancer Staging >
Nodal (N) and Metastatic (M) Disease
In the most recent published edition, the AJCC TNM staging system categorizes nodal stage based on the number of positive regional lymph nodes, rather than size. Regional lymph nodes are ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Chapter 22A: Low-Risk Noninvasive Bladder Cancer
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
What is Low-Risk Non–Muscle-Invasive Bladder Cancer?
Non–muscle-invasive urothelial cell carcinoma (UCC) of the bladder is a spectrum of fairly benign bladder tumors with a low recurrence rate and an extremely low rate of progression in patients ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Initial Diagnosis of Low-Risk NMIBC
The diagnosis of any bladder tumor, including low-risk NMIBC, is based on the recognition of complaints (predominantly hematuria), the combination of two diagnostic golden standards (cystoscopy and urinary cytology), and ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Treatment of Low-Risk Bladder Tumors
After a bladder tumor is detected on cystoscopy or imaging, patients will undergo TUR to confirm the presence of a bladder tumor, irrespective of the risk category. Guidelines indicate that ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Follow Up
As mentioned above, the risk of progression in low-risk NMIBC is very low (<1%, even after 5 years), but the risk of recurrence, even in this low-risk group, is considerable ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Ta High Grade
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Chapter 22C: Lamina Propria: Invasive Bladder Cancer (T1)
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Accurate Staging
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Prognostic Indicators
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Treatment
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Incidence
Stage Ta bladder cancer accounts for 51% to 73% of all Ta/T1 papillary lesions and 51% to 71% of all NMIBC (10,11,12). Sylvester et al. (13) reviewed 12 different series ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Pathology
The TNM classification system defines stage Ta as papillary bladder cancer confined to the mucosa. Ta bladder cancer can be identified as low grade or high grade (Fig. 22B.2). Low-grade ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Recurrence/Progression/Death
Assessment of recurrence, progression and disease-specific survival is difficult when comparing multiple studies. Limitations involved in comparing multiple studies include the use and variation of treatment following initial TURBT, presence ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Prognosis
In 2006, Sylvester et al. (7) compiled data from 2,596 patients with a known history of NMIBC from seven randomized intravesical therapy EORTC trials in an attempt to accurately predict ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Treatment
There have been no randomized controlled trials to date analyzing different treatment options in patients with Ta high-grade disease. Based on risk of progression, Ta high-grade disease should be considered ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Pathologic Classification
Accurate pathologic staging of T1 tumors from TUR specimens can be a daunting task even for a pathologist well versed in the pitfalls of pathologic staging. There is a significant ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 22. Non–Muscle-Invasive Bladder Cancer >
Pathologic Characteristics
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 1. Principles of Molecular Biology for Cancer Surgeons > Optical Coherence Tomography
Bladder cancer is the fifth most common cancer in the ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 54. Urologic Cancers: Surgical Management of Kidney, Bladder, Prostate, and Testis Cancers > Bladder Cancer
Bladder cancer represents the second most common genitourinary tumor, and ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 54. Urologic Cancers: Surgical Management of Kidney, Bladder, Prostate, and Testis Cancers > Bladder Cancer
Epidemiologic data linking cigarette smoking to bladder cancer dates back ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 54. Urologic Cancers: Surgical Management of Kidney, Bladder, Prostate, and Testis Cancers > Bladder Cancer
Bladder cancer development is a complex multistep process involving steps ...
Principles and Practice of Surgical Oncology
Principles and Practice of Surgical Oncology
Chapter 54. Urologic Cancers: Surgical Management of Kidney, Bladder, Prostate, and Testis Cancers > Radical Cystectomy
Lymphadenectomy is an integral part of the surgical treatment of ...
Human Radiation Injury
Human Radiation Injury
Chapter 32. Urinary Function > Background
Much of what is known about tolerance of the lower ...
TNM Staging Atlas with Oncoanatomy, 2e
TNM Staging Atlas with Oncoanatomy, 2e
Chapter 37. Urinary Bladder > Clinical Staging and Imaging
Primary evaluation is done preferentially under anesthesia before and after ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 17. Molecular Biology and Prognostic Markers in Bladder Cancer > Molecular Staging of Bladder Cancer
New understanding of the molecular basis for UC progression is ...
Comprehensive Textbook of Genitourinary Oncology, 4e
Comprehensive Textbook of Genitourinary Oncology, 4e
Chapter 18. Screening, Early Detection, and Prevention of Bladder Cancer > Screening and Early Detection
Bladder cancer is the fourth most common cancer in men ...
What do you think of LWWOncology?
Share Your Feedback
More Results
Journal Results from PubMed
View More on PubMed >
Terms of Use  |  Privacy  |  Help/Contact  |  Feedback
Copyright © Lippincott Williams & Wilkins. All Rights Reserved.